Capital Investment Advisory Services’s CapForce IBD 50 ETF FFTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-314
Closed -$10.2K 1106
2025
Q2
$10.2K Hold
314
﹤0.01% 941
2025
Q1
$8.46K Buy
314
+3
+1% +$88 ﹤0.01% 886
2024
Q4
$8.89K Hold
311
﹤0.01% 821
2024
Q3
$8.37K Hold
311
﹤0.01% 869
2024
Q2
$8.64K Hold
311
﹤0.01% 839
2024
Q1
$8.6K Buy
311
+2
+0.6% +$52 ﹤0.01% 836
2023
Q4
$7.53K Hold
309
﹤0.01% 858
2023
Q3
$6.92K Sell
309
-155
-33% -$3.74K ﹤0.01% 819
2023
Q2
$11.9K Hold
464
﹤0.01% 738
2023
Q1
$11K Buy
464
+13
+3% +$299 ﹤0.01% 729
2022
Q4
$9.84K Buy
+451
New +$11.1K ﹤0.01% 752

Other funds holding FFTY

Capital Investment Advisory Services's FFTY Position: Q3 2025 in Review

Capital Investment Advisory Services sold out of CapForce IBD 50 ETF (FFTY) in Q3 2025, closing a stake of 314 shares — an estimated $10.2K sold.

Capital Investment Advisory Services first reported a position in FFTY in Q4 2022 and held it in 11 quarters. The position peaked at $11.9K in Q2 2023. 40 funds tracked by Wall St. Rank hold FFTY as of Q3 2025.

  • Capital Investment Advisory Services reported no remaining CapForce IBD 50 ETF position as of Q3 2025 after selling out during the quarter.
  • Capital Investment Advisory Services sold 314 CapForce IBD 50 ETF shares in Q3 2025, an estimated $10.2K.
  • Capital Investment Advisory Services first reported a position in CapForce IBD 50 ETF in Q4 2022 and held it in 11 quarters.
  • Capital Investment Advisory Services's CapForce IBD 50 ETF position peaked at $11.9K in Q2 2023.
  • 40 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q3 2025.

Based on Capital Investment Advisory Services's 13F filing for Q3 2025, filed 5 Nov 2025.